Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03316781 · COMPLETED
Trial details
- NCT number
- NCT03316781
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2018-07-15
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.